A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : IFN

Search Conditions:
Search Keyword : IFN
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: IFN
Appearance Frequency: 20911 time(s)
Long forms: 138

Display Settings:
[Display Entries]
Long Form, 100 entries
    (Appearance freq, Descending)
Long Form, all entries
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
interferon
(19631 times)
Allergy and Immunology
(4929 times)
IL (5079 times)
TNF (2496 times)
HCV (1527 times)
1980 Effect of interferon-alpha 1 from E. coli on some cell functions.
interferon-alpha
(480 times)
Neoplasms
(163 times)
HCV (63 times)
CML (49 times)
IL-2 (26 times)
1983 Influence of human interferon-alpha therapy on cytotoxic functions of blood lymphocytes. Studies on lectin-dependent cellular cytotoxicity, antibody-dependent cellular cytotoxicity, and natural killer cell activity.
interferon-gamma
(180 times)
Allergy and Immunology
(44 times)
TNF (55 times)
LPS (27 times)
IL (22 times)
1985 Synergistic interaction of a cytokine produced by embryonic fibroblasts and a lymphokine contained in Con A-stimulated spleen cell culture for murine macrophage differentiation: a model experiment using cell line cells, M1.
alpha-interferon
(155 times)
Neoplasms
(50 times)
HCV (15 times)
HCL (14 times)
CML (11 times)
1984 In vitro protective and enhancing effects of interferons from several species on human lymphotoxin-induced target cell killing.
gamma-interferon
(84 times)
Allergy and Immunology
(16 times)
TNF (17 times)
IL (10 times)
LPS (9 times)
1984 Interferon production in primary immunodeficiencies.
IFN-gamma
(60 times)
Allergy and Immunology
(32 times)
IFNs (17 times)
GAS (3 times)
IL-2 (3 times)
1981 Effect of interferon on antibody formation.
IFN-alpha
(39 times)
Allergy and Immunology
(14 times)
IFNs (5 times)
DC (3 times)
HIV-1 (3 times)
1981 Lymphokine production by PHA-stimulated human lymphocytes is enhanced by interferon.
IFN-beta
(27 times)
Virology
(16 times)
IRF3 (4 times)
ISGs (2 times)
RIG-I (2 times)
1981 Lymphokine production by PHA-stimulated human lymphocytes is enhanced by interferon.
IFN-alphabeta
(19 times)
Allergy and Immunology
(16 times)
DCs (6 times)
ODNs (2 times)
pDCs (2 times)
1996 Overexpression of c-Fos induces apoptosis of CD43+ pro-B cells.
10  interferon-alpha/beta
(18 times)
Allergy and Immunology
(5 times)
TNF (2 times)
BDV (1 time)
BM (1 time)
1983 Enhanced responsiveness of committed macrophage precursors to macrophage-type colony-stimulating factor (CSF-1) induced in vitro by interferons alpha + beta 1.
11  IFN-lamda
(15 times)
Science
(3 times)
HSV-1 (2 times)
IFNs (2 times)
RSK1 (2 times)
2007 Human primary immunodeficiencies of type I interferons.
12  IFN-alpha and IFN-beta
(14 times)
Allergy and Immunology
(7 times)
DCs (2 times)
STING (2 times)
2AP (1 time)
1992 Two distinct pathways of interferon induction as revealed by 2-aminopurine.
13  interferon-alpha and -gamma
(11 times)
Allergy and Immunology
(6 times)
NK (3 times)
IL-2 (2 times)
ara-C (1 time)
1984 Defective interferon-gamma production in ataxia-telangiectasia.
14  infundibular nucleus
(7 times)
Metabolism
(3 times)
PVN (6 times)
NPY (2 times)
AgRP (1 time)
1986 Regional distribution of gastrin-releasing peptide- and somatostatin-like immunoreactivity in the rabbit hypothalamus.
15  interferon beta-1a
(7 times)
Neurology
(3 times)
GA (4 times)
DMT (2 times)
MSFC (2 times)
2011 Mitoxantrone prior to interferon beta-1b in aggressive relapsing multiple sclerosis: a 3-year randomised trial.
16  pegylated-interferon
(7 times)
Gastroenterology
(4 times)
HCV (3 times)
SVR (3 times)
ACR (1 time)
2004 Laparoscopic splenectomy reverses thrombocytopenia in patients with hepatitis C cirrhosis and portal hypertension.
17  TLR3-interferon
(6 times)
Therapeutics
(2 times)
IL (2 times)
Ad (1 time)
ES (1 time)
2004 Interleukin (IL)-12 and IL-23 are key cytokines for immunity against Salmonella in humans.
18  Interferon alfa
(5 times)
Gastroenterology
(2 times)
ANC (1 time)
ANN (1 time)
ANNs (1 time)
1995 Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes.
19  interferon production
(5 times)
Allergy and Immunology
(5 times)
CMI (1 time)
DAPK1 (1 time)
EZ (1 time)
1984 Effect of verapamil on interferon production, mastocyte degranulation and histamine release--studies in mice sensitized with ovalbumin.
20  interferon therapy
(4 times)
Gastroenterology
(2 times)
HCV (3 times)
HCC (2 times)
Ab (1 time)
1991 Treatment of chronic non-A, non-B hepatitis with interferon.
21  IFNbeta and IFNalpha
(3 times)
Physiology
(1 time)
AI (1 time)
DEF (1 time)
dRIG-I (1 time)
2011 Both type I and II IFN induce insulin resistance by inducing different isoforms of SOCS expression in 3T3-L1 adipocytes.
22  infliximab
(3 times)
Rheumatic Diseases
(2 times)
ADA (3 times)
ETN (3 times)
RA (2 times)
2012 Determinants of Risk Infection During Therapy with Anti TNF-Alpha Blocking Agents in Rheumatoid Arthritis.
23  interferon beta treatment
(3 times)
Allergy and Immunology
(1 time)
a-IFN (1 time)
CCR (1 time)
CM (1 time)
2003 Efficacy of interferon treatment (IFN) in elderly patients with chronic hepatitis C.
24  retinoid-interferon
(3 times)
Reproductive Medicine
(2 times)
VEGF (2 times)
IHC (1 time)
MMP (1 time)
2015 Expression of GRIM-19 in missed abortion and possible pathogenesis.
25  (Peg)-interferon
(2 times)
Gastroenterology
(1 time)
PEG (2 times)
CHB (1 time)
HCV (1 time)
2013 [Dynamic changes in programmed death-1 expression on the surface of T cells in chronic hepatitis C patients undergoing interferon therapy].
26  IFN group
(2 times)
Gastroenterology
(2 times)
123I-BMIPP (1 time)
AFP (1 time)
ECG (1 time)
2000 Early diagnosis of interferon-induced myocardial disorder in patients with chronic hepatitis C: evaluation by myocardial imaging with 123I-BMIPP.
27  IFN-alpha or beta
(2 times)
Pathology
(2 times)
SMC (1 time)
1981 Effect of interferon on antibody formation.
28  increased following interferon
(2 times)
Molecular Biology
(1 time)
AQP (1 time)
IL (1 time)
miRs (1 time)
2014 Therapeutic effect of Zeng Ye decoction on primary Sjogren's syndrome via upregulation of aquaporin‑1 and aquaporin‑5 expression levels.
29  induced for interferon
(2 times)
Allergy and Immunology
(1 time)
Con A (1 time)
IHN (1 time)
IHNV (1 time)
1997 Isoprinosine and levamisole as stimulators of interferon production in blood leukocytes of patients with alcoholic liver cirrhosis.
30  interfascicular neurons
(2 times)
Neuroanatomy
(1 time)
AC (1 time)
CC (1 time)
PC (1 time)
2002 Histological and ultrastructural characterization of interfascicular neurons in the rat anterior commissure.
31  interferon activity
(2 times)
Brain
(1 time)
Con A (1 time)
PBMC (1 time)
SSPE (1 time)
1983 Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets.
32  interferon type I
(2 times)
Neoplasms
(1 time)
FISH (1 time)
IL-17A (1 time)
PBMCs (1 time)
1995 Detection of CDKN2 deletions in tumor cell lines and primary glioma by interphase fluorescence in situ hybridization.
33  interferon-alpha therapy
(2 times)
Substance-Related Disorders
(1 time)
HCV (1 time)
SUD (1 time)
SUDs (1 time)
2001 Endothelial dysfunction and decreased exercise tolerance in interferon-alpha therapy in chronic hepatitis C: relation between exercise hyperemia and endothelial function.
34  pegylated-interferon alpha
(2 times)
Gastroenterology
(1 time)
RBV (2 times)
DAA (1 time)
DAAs (1 time)
2011 Hepatitis C Viral Kinetics in the Era of Direct Acting Antiviral Agents and IL28B.
35  type-I-interferon
(2 times)
Allergy and Immunology
(2 times)
TNF (1 time)
1999 Bovine monocytoid cells transformed to proliferate cease to exhibit lineage-specific functions.
36  ABZ-interferon
(1 time)
Parasitology
(1 time)
ABZ (1 time)
CE (1 time)
2017 In vivo evaluation of the efficacy of combined albedazole-IFN-alpha treatment for cystic echinococcosis in mice.
37  alpha-IFN
(1 time)
Neurology
(1 time)
MS (1 time)
RR (1 time)
2003 [Interferon-alpha2b recombinant improved the cognitive dysfunction in patients with relapsing remitting multiple sclerosis].
38  cAMP-induced NK suppression and interferon
(1 time)
Allergy and Immunology
(1 time)
cAMP (1 time)
NK (1 time)
PGE1 (1 time)
1983 Inhibition of human NK cell cytotoxicity by induction of cyclic AMP depends on impaired target cell recognition.
39  cytokines-interferon
(1 time)
Medicine
(1 time)
CAG (1 time)
GAC (1 time)
IL (1 time)
2016 Local Immune Response in Helicobacter pylori Infection.
40  DAV-interferon
(1 time)
Dermatology
(1 time)
VCR (1 time)
2013 Postoperative DAV-IFN-beta therapy does not improve survival rates of stage II and stage III melanoma patients significantly.
41  families-interferon
(1 time)
Antineoplastic Agents
(1 time)
TRAIL (1 time)
2012 A 71-gene signature of TRAIL sensitivity in cancer cells.
42  Fe-inefficient
(1 time)
Plant Physiological Phenomena
(1 time)
EF (1 time)
IDC (1 time)
VCR (1 time)
2017 Insights into Resistance to Fe Deficiency Stress from a Comparative Study of In Vitro-Selected Novel Fe-Efficient and Fe-Inefficient Potato Plants.
43  i.e. for interferon
(1 time)
General Surgery
(1 time)
AP (1 time)
CD (1 time)
CP (1 time)
2003 Immunological findings in acute and chronic pancreatitis.
44  idiopathic facial nerve/Bell's palsy
(1 time)
General Surgery
(1 time)
ARS (1 time)
OCSs (1 time)
OtoHNS (1 time)
2016 Oral corticosteroid prescribing habits of Canadian Otolaryngologist-Head and Neck Surgeons.
45  ifenprodil
(1 time)
Neurology
(1 time)
AMPAR (1 time)
ANI (1 time)
BLA (1 time)
2016 Involvement of protein phosphatases in the destabilization of methamphetamine-associated contextual memory.
46  IFN responsive genes
(1 time)
Biotechnology
(1 time)
MSTN (1 time)
RNAi (1 time)
SCNT (1 time)
2016 Effect of Co-transfection of Anti-myostatin shRNA Constructs in Caprine Fetal Fibroblast Cells.
47  IFN, and who were treated with combination therapy
(1 time)
Drug Therapy
(1 time)
--- 1999 [Early prediction of lack of response to treatment with interferon and interferon plus ribavirin using biochemical and virological criteria in patients with chronic hepatitis C].
48  IFN-alpha, IFN-beta, and IFN-gamma
(1 time)
Allergy and Immunology
(1 time)
--- 1988 Recombinant human IFN-gamma, but not IFN-alpha or IFN-beta, enhances MHC- and non-MHC-encoded glycoproteins by a protein synthesis-dependent mechanism.
49  IFN-alpha, IFN-beta, and MxA
(1 time)
Virology
(1 time)
huTRIM5alpha (1 time)
IFNs (1 time)
MxA (1 time)
2011 Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infection.
50  IFN-alpha-, adaptive cytokines - interferon
(1 time)
Gastroenterology
(1 time)
CD (1 time)
G-CSF (1 time)
GM-CSF (1 time)
2016 Innate and adaptive immunity in self-reported nonceliac gluten sensitivity versus celiac disease.
51  IFN-based therapy
(1 time)
Virology
(1 time)
HCV (1 time)
IFN-lamda3 (1 time)
SVR (1 time)
2015 Interferon lambda-3 is not associated with clinical outcome in patients with HCV-induced compensated cirrhosis: a long-term cohort study.
52  IFN-DCs
(1 time)
Allergy and Immunology
(1 time)
DCs (1 time)
2003 Monocyte-derived dendritic cells generated after a short-term culture with IFN-alpha and granulocyte-macrophage colony-stimulating factor stimulate a potent Epstein-Barr virus-specific CD8+ T cell response.
53  IFN-free regimens
(1 time)
Rheumatology
(1 time)
CV (1 time)
DAAs (1 time)
HCV (1 time)
2015 HCV Treatments and Their Integration Into Rheumatology.
54  IFN-g
(1 time)
Pharmacology
(1 time)
IFNs (1 time)
1999 Interferons and their role In inflammation.
55  IFN-I or IFN-alphabeta
(1 time)
Allergy and Immunology
(1 time)
--- 2005 Depletion of T cells by type I interferon: differences between young and aged mice.
56  IFN-III or IFN-lamda
(1 time)
Virology
(1 time)
DENV (1 time)
DENV-2 (1 time)
ISGs (1 time)
2015 Interferon lambda inhibits dengue virus replication in epithelial cells.
57  IFN-Le
(1 time)
Hematology
(1 time)
CSF (1 time)
1984 The effects of interferon on granulopoiesis in vitro.
58  IFNG gene encoding interferon
(1 time)
Medicine
(1 time)
CAA (1 time)
CAL (1 time)
IVIG (1 time)
2016 Interferon-gamma Genetic Polymorphism and Expression in Kawasaki Disease.
59  IL-23 facilitates interferon
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
HCV (1 time)
IL (1 time)
ISGs (1 time)
2014 Inteleukin-23 promotes interferon-alpha responsiveness in hepatitis C virus/HIV-coinfected patients.
60  IL-27 treated DCs showed no up-regulation of Type I
(1 time)
Medicine
(1 time)
DCs (1 time)
iDCs (1 time)
mDCs (1 time)
2013 Interleukin-27 is a potent inhibitor of cis HIV-1 replication in monocyte-derived dendritic cells via a type I interferon-independent pathway.
61  IL-6, neutrophil elastase and interferon
(1 time)
Dermatology
(1 time)
IL (1 time)
TNF (1 time)
2000 Elafin is induced in epidermis in skin disorders with dermal neutrophilic infiltration: interleukin-1 beta and tumour necrosis factor-alpha stimulate its secretion in vitro.
62  imatinib+interferon
(1 time)
Neoplasms
(1 time)
CML (1 time)
2014 Interferon decreases VEGF levels in patients with chronic myeloid leukemia treated with imatinib.
63  immune functions of IL-27, interferon
(1 time)
Complementary Therapies
(1 time)
IL (1 time)
MPE (1 time)
STAT (1 time)
2015 Immune Regulation of Interleukin-27 in Malignant Pleural Effusion.
64  immune-regulatory functions including interferon
(1 time)
Molecular Biology
(1 time)
CTL (1 time)
EBNA1 (1 time)
EBV (1 time)
2002 Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex.
65  immunity as well as the release of cytokines
(1 time)
Allergy and Immunology
(1 time)
PRL (1 time)
1995 Effect of domperidone-induced hyperprolactinemia on selected immune parameters in healthy women.
66  immunoassay for interferon
(1 time)
Dermatology
(1 time)
IL (1 time)
Mtb (1 time)
TST (1 time)
2010 Decrease in Mycobacterium tuberculosis specific immune responses in patients with untreated psoriasis living in a tuberculosis endemic area.
67  immunofluorescent nanosphere
(1 time)
Chemistry Techniques, Analytical
(1 time)
CRP (1 time)
FN (1 time)
FNs (1 time)
2016 Sensitive and Quantitative Detection of C-Reaction Protein Based on Immunofluorescent Nanospheres Coupled with Lateral Flow Test Strip.
68  immunoregulatory function of interferon
(1 time)
EAE (1 time)
IBD (1 time)
MS (1 time)
2016 IL-10 Modulates Th17 Pathogenicity during Autoimmune Diseases.
69  immunospot-interferon
(1 time)
Allergy and Immunology
(1 time)
BP (1 time)
HLA (1 time)
HPV-16 (1 time)
2010 Human papillomavirus 16-specific T cell responses in classic HPV-related vulvar intra-epithelial neoplasia. Determination of strongly immunogenic regions from E6 and E7 proteins.
70  impact of treatment
(1 time)
Gastroenterology
(1 time)
--- 2003 Risk factors for liver fibrosis progression in patients with chronic hepatitis C.
71  impaired NK-cell functions, including interferon
(1 time)
Allergy and Immunology
(1 time)
CHB (1 time)
DiD (1 time)
HBV (1 time)
2017 Exosomes mediate hepatitis B virus (HBV) transmission and NK-cell dysfunction.
72  important for type I interferon
(1 time)
Virology
(1 time)
NPs (1 time)
PICV (1 time)
RNase (1 time)
2015 In vitro and in vivo characterizations of pichinde viral nucleoprotein exoribonuclease functions.
73  Importantly, NKp46-CD8alphaalpha-Ly49E+ cells produce interferon
(1 time)
Biological Science Disciplines
(1 time)
ILC1 (1 time)
NK (1 time)
2017 A Murine Intestinal Intraepithelial NKp46-Negative Innate Lymphoid Cell Population Characterized by Group 1 Properties.
74  in situ formation/release of interferon
(1 time)
Allergy and Immunology
(1 time)
GM-CSF (1 time)
IL (1 time)
TNF (1 time)
2015 Acacia ferruginea inhibits cyclophosphamide-induced immunosuppression and urotoxicity by modulating cytokines in mice.
75  in vitro for human leucocyte interferon
(1 time)
Hematology
(1 time)
HTCA (1 time)
MM (1 time)
1985 Correlation between in vitro and in vivo sensitivity to human leucocyte interferon in patients with multiple myeloma.
76  in vitro, fucoidan amplified interferon
(1 time)
Genetics, Medical
(1 time)
IL (1 time)
LAB (1 time)
2012 A sulfated polysaccharide, fucoidan, enhances the immunomodulatory effects of lactic acid bacteria.
77  includes the production of antiviral
(1 time)
Allergy and Immunology
(1 time)
IFNs (1 time)
PAMPs (1 time)
SOCS (1 time)
2009 Interferons: signaling, antiviral and viral evasion.
78  including non-pegylated ('standard') interferon alfa
(1 time)
Health Services Research
(1 time)
ADV (1 time)
CHB (1 time)
HRQoL (1 time)
2006 Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
79  incorporation following stimulation with interferon
(1 time)
Hematology
(1 time)
CLL (1 time)
1986 Interferon induces proliferation in leukemic and normal B-cell subsets.
80  increased frequency of interferon
(1 time)
Communicable Diseases
(1 time)
HIV (1 time)
2011 Possession of HLA class II DRB1*1303 associates with reduced viral loads in chronic HIV-1 clade C and B infection.
81  increased nuclear translocation of interferon
(1 time)
Tropical Medicine
(1 time)
IRF7 (1 time)
2011 Activation of the innate immune response against DENV in normal non-transformed human fibroblasts.
82  increased number of interferon
(1 time)
Natural Science Disciplines
(1 time)
DC (1 time)
IL-28A (1 time)
NK (1 time)
2017 Interleukin-28B dampens airway inflammation through up-regulation of natural killer cell-derived IFN-gamma.
83  indicating decreased quality of life
(1 time)
Public Health
(1 time)
DAAs (1 time)
HCV (1 time)
HRQoL (1 time)
2018 Evaluation of health status in patients with hepatitis c treated with and without interferon.
84  indistinguishable from gamma interferon
(1 time)
Allergy and Immunology
(1 time)
PMA (1 time)
1982 Macrophage activation for tumor cytotoxicity: induction of macrophage tumoricidal activity by lymphokines from EL-4, a continuous T cell line.
85  induced neither interferon
(1 time)
Allergy and Immunology
(1 time)
HCV (1 time)
HD (1 time)
TNF (1 time)
2013 Hepatitis C patients on maintenance hemodialysis show complex immune disturbances in the peripheral blood.
86  inducible HO-1 mRNA by LPS or LPS+interferon
(1 time)
Biochemistry
(1 time)
HO-1 (1 time)
iNOS (1 time)
LPS (1 time)
2015 Nitric oxide is an important regulator of heme oxygenase-1 expression in the lipopolysaccharide and interferon-gamma-treated murine macrophage-like cell line J774.1/JA-4.
87  inducible nitrite synthase (iNOS), interferon
(1 time)
Veterinary Medicine
(1 time)
AGP (1 time)
CER (1 time)
FM (1 time)
2009 Effects of dietary glycine supplementation and fish meal on inflammatory responses in broiler chicks.
88  inducible NO synthase, interferon
(1 time)
Nutritional Sciences
(1 time)
CER (1 time)
Glu (1 time)
Gly (1 time)
2008 Dietary supplementation of glycine modulates inflammatory response indicators in broiler chickens.
89  inducing several hundred cellular genes, aptly named 'interferon
(1 time)
Virology
(1 time)
NS (1 time)
PVM (1 time)
RSV (1 time)
2017 The nonstructural proteins of Pneumoviruses are remarkably distinct in substrate diversity and specificity.
90  induction following interferon
(1 time)
Allergy and Immunology
(1 time)
HCV (1 time)
ISG (1 time)
SOCS (1 time)
2015 The Mechanism of Interferon Refractoriness During Hepatitis C Virus Infection and Its Reversal with a Peroxisome Proliferator-Activated Receptor alpha Agonist.
91  infected newborn mice with interferon-alpha
(1 time)
General Surgery
(1 time)
EHBA (1 time)
RRV (1 time)
1998 Progress in developing animal models for biliary atresia.
92  infection fails to induce interferon-alphabeta
(1 time)
Microbiology
(1 time)
HBV (1 time)
LUBAC (1 time)
pgRNA (1 time)
2016 Hepatitis B Virus-Induced Parkin-Dependent Recruitment of Linear Ubiquitin Assembly Complex (LUBAC) to Mitochondria and Attenuation of Innate Immunity.
93  inflammatory factors, such as interferon
(1 time)
Biochemistry
(1 time)
BALF (1 time)
ELISA (1 time)
IL (1 time)
2018 Thymic Stromal Lymphopoietin Signaling Pathway Inhibition Attenuates Airway Inflammation and Remodeling in Rats with Asthma.
94  inflammatory foci-negative
(1 time)
Tropical Medicine
(1 time)
IFP (1 time)
MCS (1 time)
RS (1 time)
1998 Polymerase chain reaction amplification of three different Trypanosoma cruzi DNA sequences from human chagasic cardiac tissue.
95  influenced the resistance to exogenous
(1 time)
Medicine
(1 time)
AA (1 time)
ASA (1 time)
1995 [Treatment of chronic virus hepatitis with acetylsalicylic acid].
96  influencing factors of the interferon
(1 time)
Gastroenterology
(1 time)
ETVR (1 time)
SVR (1 time)
2006 [Retreatment with interferon of relapsed chronic hepatitis C patients].
97  inherent feature of interferon
(1 time)
Allergy and Immunology
(1 time)
--- 2000 Engineered acid-stabile human interferon gamma.
98  inhibit neoplastic growth--interferon alpha-2/alpha-1 hybrid
(1 time)
Medicine
(1 time)
IUdR (1 time)
MGBG (1 time)
1999 Effect of 3 growth control substances on foreign body sarcomagenesis: IFN, IUdR, MGBG.
99  inhibited nuclear factor-kappaB and interferon
(1 time)
Pharmacology
(1 time)
MyD88 (1 time)
TLRs (1 time)
TRIF (1 time)
2010 TBK1-targeted suppression of TRIF-dependent signaling pathway of toll-like receptor 3 by auranofin.
100  iNOS and TNF protein levels in M
(1 time)
Biotechnology
(1 time)
hMSC (1 time)
IA (1 time)
MPA (1 time)
2018 Initial In Vitro Development of a Potassium-Based Intra-Articular Injection for Osteoarthritis.